Evidence map›Paper›PMID 19008529›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2009

HDL remodeling during the acute phase response.

Anisa Jahangiri, Maria C de Beer, Victoria Noffsinger, Lisa R Tannock, Chandrashekar Ramaiah, Nancy R Webb, Deneys R van der Westhuyzen, Frederick C de Beer

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it, 135 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Serum Amyloid A: A Double-Edged Sword in Health and Disease.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Exposure ofEnvironmental health perspectives · 2024
    Article
  11. Article
  12. Article
  13. Can "Bad" HDL Be Turned Good Again?Arteriosclerosis, thrombosis, and vascular biology · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. High-density lipoprotein infusion protects from acute graft-versus-host disease in experimental allogeneic hematopoietic cell transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  18. Observational
  19. Article
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Anisa JahangiriDepartment of Internal Medicine, Division of Endocrinology and Molecular Medicine, University of Kentucky, Lexington, KY, USA. anisa.jahangiri@uky.edu
Maria C de Beer
Victoria Noffsinger
Lisa R Tannock
Chandrashekar Ramaiah
Nancy R Webb
Deneys R van der Westhuyzen
Frederick C de Beer
United States Nuclear Regulatory Commission · US

Funding

Mouse CoreP01HL086670 · NHLBI · UNIVERSITY OF KENTUCKY · PI VAN DER WESTHUYZEN, DENEYS REM · 2007 to 2011
$7.1M
NHLBI NIH HHS P01 HL086670NHLBI NIH HHS P01HL086670
6 · The paper itself

Abstract

objectiveThe purpose of this study was to examine the interactive action of serum amyloid A (SAA), group IIA secretory phospholipase A(2) (sPLA(2)-IIA), and cholesteryl ester transfer protein (CETP) on HDL remodeling and cholesterol efflux during the acute phase (AP) response elicited in humans after cardiac surgery. METHODS AND

resultsPlasma was collected from patients before (pre-AP), 24 hours after (AP-1 d), and 5 days after cardiac surgery (AP-5 d). SAA levels were increased 16-fold in AP-1 d samples. The activity of sPLA(2)-IIA was increased from 77.7+/-38.3 U/mL (pre-AP) to 281.4+/-57.1 U/mL (AP-1 d; P<0.001). CETP mass and activity reduction was commensurate to the reduction of HDL cholesterol levels. The combined action of SAA, sPLA(2)-IIA, and CETP in vitro markedly remodeled HDL with the generation of lipid-poor apoA-I from both pre-AP and AP-1 d HDL. The net result of this remodeling was a relative preservation of ABCA1- and ABCG1-dependent cholesterol efflux during the acute phase response.

conclusionsOur results show that the many and complex changes in plasma proteins during the acute phase response markedly remodel HDL with functional implications, particularly the relative retention of cholesterol efflux capacity.

Indexed as

Acute-Phase ReactionApolipoprotein A-IATP Binding Cassette Transporter 1ATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily G, Member 1Cardiac Surgical ProceduresCholesterolCholesterol Ester Transfer ProteinsChromatography, AffinityGroup II Phospholipases A2HumansLipoproteins, HDLMacrophagesRecombinant ProteinsSerum Amyloid A ProteinTime FactorsABCA1 protein, humanABCG1 protein, humanAPOA1 protein, humanApolipoprotein A-IATP Binding Cassette Transporter 1ATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily G, Member 1CETP protein, humanCholesterolCholesterol Ester Transfer ProteinsGroup II Phospholipases A2Lipoproteins, HDLRecombinant ProteinsSerum Amyloid A Protein

Identifiers

PMID19008529
PMCPMC2760005
OpenAlexW2098667524

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.